Page breadcrumb nav

VAERS Report 2156945

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: fk0112


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2021-11-01
Date d’apparition
8
Nombre de jours (date d’apparition – date de vaccination)
8
Description de l’événement indésirable

photopsia/ visual flashes; tinnitus aggravated; migraine; retinal migraine; tearfulness; injection site pain; visual disturbance; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from a regulatory authority. the reporter is the patient. regulatory number: gb-mhra-webcovid-202202272113366630-mvbrw. other case identifier(s): gb-mhra-adr 26657297. a female patient received bnt162b2 (comirnaty), administration date nov2021 (lot number: fk0112) as dose 3 (booster), single for covid-19 immunisation. relevant medical history included: "tinnitus" (unspecified if ongoing). the patient's concomitant medications were not reported. vaccination history included: bnt162b2 (dose 2, single, lot number: em4965), administration date: apr2021, for covid-19 immunisation; bnt162b2 (dose 1, single, lot number: unknown), for covid-19 immunisation. the following information was reported: visual impairment (disability, medically significant) with onset 2021, outcome "recovering", described as "visual disturbance"; photopsia (disability, medically significant) with onset 25nov2021, outcome "not recovered", described as "photopsia/ visual flashes"; tinnitus (disability, medically significant) with onset 25nov2021, outcome "not recovered", described as "tinnitus aggravated"; migraine (disability, medically significant) with onset 25nov2021, outcome "not recovered", described as "migraine"; retinal migraine (disability, medically significant) with onset 25nov2021, outcome "not recovered", described as "retinal migraine"; tearfulness (disability, medically significant) with onset 25nov2021, outcome "not recovered", described as "tearfulness"; vaccination site pain (disability, medically significant) with onset 09nov2021, outcome "recovered" (16nov2021), described as "injection site pain". the patient reported that exactly two weeks after booster new visual disturbance (flashing) started and it had continued, it affects all aspects of life. the patient underwent the following laboratory tests and procedures: investigation: unknown results; magnetic resonance imaging: unknown results. the patient had numerous investigations, spent a lot of time and money looking for answers of opthalmic reports, mris etc and truly with the patient never had the booster. the patient had not tested positive for covid-19 since having the vaccine. no follow-up attempts are possible. no further information is expected

Données de laboratoire
test name: investigations; result unstructured data: test result:unknown results; test name: mris; result unstructured data: test result:unknown results
Liste des symptômes
investigation tinnitus migraine photopsia magnetic resonance imaging visual impairment vaccination site pain tearfulness retinal migraine
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Oui
Allergies:
na
Maladie actuelle
na